Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone.
Belhassen-García M, Sánchez-Puente A, Dorado-Díaz PI, López-Bernús A, Sampedro-Gómez J, Azibeiro-Melchor R, Marcano-Millán E, Rodríguez-Alonso B, Sánchez-Barrado ME, Hernández-García I, Madruga I, Hernández-Pérez G, Carbonell C, García-Aparicio J, Burgos L, López-Sánchez E, Reina C, Ramón AM, Cestero-Ramírez L, Boumhir F, Encinas-Sánchez D, Sánchez-Ledesma M, Herráez J, Araoz P, Sánchez-Crespo MJ, Rodríguez-Rodríguez S, Rodríguez-Gude AE, Sánchez-Hernández MV, Borrás R, Sagredo-Meneses V, Sánchez PL, Marcos M, Martín-Oterino JÁ.
Belhassen-García M, et al. Among authors: burgos l.
J Clin Med. 2021 Dec 30;11(1):198. doi: 10.3390/jcm11010198.
J Clin Med. 2021.
PMID: 35011938
Free PMC article.